LMR Partners LLP: HVII position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of LMR Partners LLP on HVII, newest first. How the timeline and the estimate are built.
LMR Partners LLP held 350,000 HVII shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 350,000 sharesChange vs previous 13F 0 shares
0.03% of the 13F portfolio, value $3,657,500.
13F-HR 0001578621-26-000147 filed by LMR Partners LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 350,000 sharesChange vs previous 13F 0 shares
0.03% of the 13F portfolio, value $3,622,500.
13F-HR 0001578621-26-000093 filed by LMR Partners LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 350,000 sharesChange vs previous 13F -100,000 shares
0.03% of the 13F portfolio, value $3,622,500.
13F-HR 0001578621-26-000003 filed by LMR Partners LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 450,000 sharesChange vs previous 13F 0 shares
0.06% of the 13F portfolio, value $4,585,500.
13F-HR 0001578621-25-000014 filed by LMR Partners LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 450,000 sharesChange vs previous 13F 0 shares
0.07% of the 13F portfolio, value $4,572,000.
13F-HR 0002069324-25-000006 filed by LMR Partners LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 450,000 sharesChange vs previous 13F not available
0.09% of the 13F portfolio, value $4,446,000.
13F-HR 0001578621-25-000009 filed by LMR Partners LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).